Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02625051 · ClinicalTrials.gov registry record · NA

Quality of Life in Kidney Stone Patients Undergoing Surgery

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT02625051 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02625051, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

This is a prospective randomized study, comparing quality of life in renal stone patients undergoing surgical treatment with ureteroscopy (URS) versus percutaneous nephrolithotomy (PNL).

Interventions

  • PROCEDURE Ureteroscopy
  • PROCEDURE Percutaneous nephrolithotomy

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2016-07
Est. Completion 2019-06-30
Phase NA

What the Registry Record Tells You About NCT02625051

The ClinicalTrials.gov registry entry for NCT02625051 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Ureteroscopy is the first listed.

NCT02625051 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02625051 about?

NCT02625051 is a clinical study titled "Quality of Life in Kidney Stone Patients Undergoing Surgery". This is a prospective randomized study, comparing quality of life in renal stone patients undergoing surgical treatment with ureteroscopy (URS) versus percutaneous nephrolithotomy (PNL).

What is the current status of trial NCT02625051?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-07. Estimated completion is 2019-06-30.

What interventions are being tested in trial NCT02625051?

The interventions under investigation include: Ureteroscopy (PROCEDURE), Percutaneous nephrolithotomy (PROCEDURE).

Who is sponsoring clinical trial NCT02625051?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.